Teijin, BioVaram sign pact to deliver next-generation medical solutions
I'm PortAI, I can summarize articles.
Hyderabad-based BioVaram has signed a Memorandum of Understanding (MoU) with Japan's Teijin Limited to enhance the use of regenerative medicine products and implantable medical devices in India and Japan. The collaboration will focus on regulatory approval and commercialization of Teijin's cardiovascular repair patch in India and will facilitate the introduction of BioVaram's technologies in Japan. This partnership aims to strengthen research and manufacturing capabilities in advanced tissue engineering products, marking a significant step in Teijin's global expansion efforts.
Source: Business Standard The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments